<SUBMISSION>
<ACCESSION-NUMBER>0000950135-05-004209
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20050721
<ITEMS>1.01
<FILING-DATE>20050727
<DATE-OF-FILING-DATE-CHANGE>20050727
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AKAMAI TECHNOLOGIES INC
<CIK>0001086222
<ASSIGNED-SIC>7389
<IRS-NUMBER>043432319
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-27275
<FILM-NUMBER>05977993
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>8 CAMBRIDGE CENTER
<CITY>CAMBRIDGE
<STATE>MA
<ZIP>02142
<PHONE>6174443000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>8 CAMBRIDGE CENTER
<CITY>CAMBRIDGE
<STATE>MA
<ZIP>02142
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>b55983ake8vk.htm
<DESCRIPTION>AKAMAI TECHNOLOGIES, INC.
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, D.C. 20549<BR>
<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>


<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of the<BR>
Securities Exchange Act of 1934</B>


<P align="center" style="font-size: 10pt"><b>Date of report (Date of
earliest event reported): <U>July&nbsp;21, 2005</U></b>


<P align="center" style="font-size: 24pt"><B>AKAMAI TECHNOLOGIES, INC.</B>
<DIV align="center"><DIV style="font-size: 3pt; margin-top: 3pt; width: 100%; border-top: 1px solid #000000">&nbsp;</DIV>

<DIV align="center" style="font-size: 10pt">(Exact Name of Registrant as Specified in Charter)</DIV>



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">Delaware
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">0-27275
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">04-3432319</TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other Jurisdiction<BR>
of Incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">8 Cambridge Center, Cambridge, Massachusetts
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">02142</TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>




<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: <U>(617)&nbsp;444-3000</U>


<P align="left" style="margin-left: 0%; text-indent: 0%; margin-right: 0%; font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<i>see</I> General Instruction A.2. below):


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><FONT face="wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17
CFR 230.425)</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><FONT face="wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR
240.14a-12)</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><FONT face="wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><FONT face="wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</div>



<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="left" style="font-size: 10pt"><B>Item&nbsp;1.01 Entry into Material Definitive Agreement</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On July&nbsp;21, 2005, the Compensation Committee (the &#147;Compensation Committee&#148;) of the Board of
Directors of Akamai Technologies, Inc. (&#147;Akamai&#148;) granted options with incentive-based vesting
acceleration provisions to Akamai employees including the following executive officers: Lisa
Arthur, George Conrades, Melanie Haratunian, Robert Hughes, Paul Sagan and Chris Schoettle. The
options have the following base vesting schedule: 25% vest on the first anniversary of the date of
grant and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. In addition,
vesting shall accelerate, in whole or in part, for then-unvested options if Akamai achieves
enumerated revenue and earnings per share objectives before or during the fiscal year ending
December&nbsp;31, 2007. The terms of the option agreements are more fully described in the form of
incentive stock option agreement attached hereto, and incorporated by reference herein, as Exhibit
99.1 (the &#147;Form&nbsp;Agreement&#148;).


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, on July&nbsp;1, 2005, the Compensation Committee approved a compensation package for
the Executive Chairman of the Board of Directors, George Conrades. The Executive Chairman shall be
paid the following annual compensation: $20,000 in cash and $180,000 in deferred stock units (with
the number of units issued based on the closing sale price of Akamai&#146;s common stock on the date of
grant).


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="center" style="font-size: 10pt"><B>SIGNATURE</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">Date:  July 27, 2005&nbsp;</TD>
    <TD colspan="3" align="left">AKAMAI TECHNOLOGIES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">
/s/ Melanie Haratunian
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Melanie Haratunian, Vice President and&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">General Counsel&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="95%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">Exhibit</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Akamai Technologies, Inc. Form of Incentive Stock
Option Agreement</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>b55983akexv99w1.htm
<DESCRIPTION>EX-99.1 FORM OF INCENTIVE STOCK OPTION AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.1 Form of Incentive Stock Option Agreement</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U><b>EXHIBIT
99.1</b></U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AKAMAI TECHNOLOGIES, INC.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Incentive Stock Option Agreement<BR>
<U>Granted Under 1998 Stock Incentive Plan</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">1. <U>Grant of Option</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Incentive Stock Option Agreement (this &#147;Agreement&#148;) evidences the grant by Akamai
Technologies, Inc., a Delaware corporation (the &#147;Company&#148;), on &#171;Grant_Date&#187; (the &#147;Grant Date&#148;) to
&#171;First_&#187; &#171;Last&#187;, an employee of the Company (the &#147;Participant&#148;), of an option to purchase, in whole
or in part, on the terms provided herein and in the Company&#146;s Second Amended and Restated 1998
Stock Incentive Plan (the &#147;Plan&#148;), a total of &#171;Shares_Granted_&#187; shares (the &#147;Shares&#148;) of common
stock, $0.01 par value per share, of the Company (&#147;Common Stock&#148;) at &#171;Price_&#187; per Share. Unless
earlier terminated, this option shall expire on &#171;Expire&#187; (the &#147;Final Exercise Date&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It is intended that the option evidenced by this agreement shall, to the extent it so
qualifies, be an incentive stock option as defined in Section&nbsp;422 of the Internal Revenue Code of
1986, as amended and any regulations promulgated there under (the &#147;Code&#148;). Schedule&nbsp;A hereto sets
forth the number of shares with respect to which this option qualifies as an incentive stock option
as of the date of grant. To the extent that the option does not on the date of grant, or hereafter
ceases to, qualify as an incentive stock option, it shall be a non-qualified stock option. Except
as otherwise indicated by the context, the term &#147;Participant&#148;, as used in this option, shall be
deemed to include any person who acquires the right to exercise this option validly under its
terms.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">2. <U>Vesting Schedule</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>General</U>. This option will become exercisable (&#147;vest&#148;) as to 25% of the original
number of Shares on the first anniversary of the Grant Date and as to an additional 6.25% of the
original number of Shares at the end of each successive full three-month period following the
second anniversary of the Grant Date until the fourth anniversary of the Grant Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Accelerated Vesting upon Certain Corporate Milestones</U>. In the event the Company
achieves one of the performance targets set forth in clauses (i)&nbsp;through (viii)&nbsp;below during or
prior to the fiscal year ending December&nbsp;31, 2007 (&#147;FY 2007&#148;), the indicated portion of the option
evidenced by this Agreement will vest on an accelerated basis effective on the 15<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day
following the Reporting Date (as defined below):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;In the event that the Company achieves both its Cash EPS Target (as defined below) and its
Sales Revenue Target (as defined below) during the same fiscal year, this option will automatically
vest as to 100% of the unvested Shares outstanding as of the Reporting Date.
</DIV>

<P align="center" style="font-size: 10pt">Page 1 of 7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;In the event that the Company achieves its Cash EPS Target and at least 92.135% but less
than 100% of its Sales Revenue Target during the same fiscal year, this option will automatically
vest as to 75% of the unvested Shares outstanding as of the Reporting Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;In the event that the Company achieves its Cash EPS Target but less than 92.135% of its
Sales Revenue Target during the same fiscal year, this option will automatically vest as to 50% of
the unvested Shares outstanding as of the Reporting Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;In the event that the Company achieves at least 93.333% but less than 100% of its Cash
EPS Target and 100% of its Sales Revenue Target during the same fiscal year, this option will
automatically vest as to 75% of the unvested Shares outstanding as of the Reporting Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;In the event that the Company achieves less than 93.333% of its Cash EPS Target and 100%
of its Sales Revenue Target during the same fiscal year, this option will automatically vest as to
50% of the unvested Shares outstanding as of the Reporting Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;In the event that the Company achieves at least 93.333% but less than 100% of its Cash
EPS Target and at least 92.135% but less than 100% of its Sales Revenue Target during the same
fiscal year, this option will automatically vest as to 50% of the unvested Shares outstanding as of
the Reporting Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;In the event that the Company achieves at least 93.333% but less than 100% of its Cash
EPS Target but less than 92.135% of its Sales Revenue Target during the same fiscal year, this
option will automatically vest as to 25% of the unvested Shares outstanding as of the Reporting
Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;In the event that the Company achieves less than 93.333% of its Cash EPS Target and at
least 92.135% but less than 100% of its Sales Revenue Target during the same fiscal year, this
option will automatically vest as to 25% of the unvested Shares outstanding as of the Reporting
Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following definitions shall apply to this Section&nbsp;2(b):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Cash EPS Target&#148; shall mean the Company shall have earned annual earnings per diluted
share (on a fiscal year basis) calculated in accordance with generally accepted accounting
principles in the United States of America excluding non-cash charges (e.g., income taxes, equity
compensation expense and amortization of acquired intangible assets) of at least $XXXX per share as
reported, (y)&nbsp;for so long as the Company is required to make periodic reports under the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), in the Company&#146;s consolidated financial
statements filed with the Securities and Exchange Commission on Form 10-K (&#147;Public Company
Financial Statements&#148;), or (z)&nbsp;at such time as the Company is not required to make periodic reports
under the Exchange Act, in the Company&#146;s
</DIV>

<P align="center" style="font-size: 10pt">Page 2 of 7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">regularly prepared annual audited financial statements prepared by management (&#147;Private Company
Financial Statements&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Sales Revenue Target&#148; shall mean the Company shall have earned annual revenue (on a
fiscal year basis) calculated in accordance with generally accepted accounting principles in the
United States of America of at least $XXXX million as reported, (y)&nbsp;for so long as the Company is
required to make periodic reports under the Exchange Act, in the Company&#146;s Public Company
Financial Statements or (z)&nbsp;at such time as the Company is not required to make periodic reports
under the Exchange Act, in the Company&#146;s Private Company Financial Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Reporting Date&#148; shall mean, in the event the Company achieves one of the targets
described in clauses (i)&nbsp;through (viii)&nbsp;above, the date on which the Company files its annual
Public Company Financial Statements for FY 2007 or, in the event that the Company is not required
to make periodic reports under the Exchange Act, the date on which audited annual Private Company
Financial Statements for FY 2007 have been completed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The right of exercise shall be cumulative so that to the extent the option is not
exercised in any period to the maximum extent permissible it shall continue to be exercisable, in
whole or in part, with respect to all shares for which it is vested until the earlier of the Final
Exercise Date or the termination of this option under Section&nbsp;3 hereof or the Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change in Control</U>. Upon a Change in Control Event (as defined in the Plan), the
number of Shares as to which this option has vested shall be calculated pursuant to Section 2(a) as
though the Grant Date were the date that is one year prior to the Grant Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">3. <U>Exercise of Option</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Form of Exercise</U>. In order to exercise this option, the Participant shall notify
the Company&#146;s third-party stock option plan administrator, Charles Schwab &#038; Co., or any successor
appointed by the Company (the &#147;Plan Administrator&#148;), of the Participant&#146;s intent to exercise this
option, and shall follow the procedures established by the Plan Administrator for exercising stock
options under the Plan and provide payment in full in the manner provided in the Plan. The
Participant may purchase less than the number of shares covered hereby, provided that no partial
exercise of this option may be for any fractional share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Continuous Relationship with the Company Required</U>. Except as otherwise provided
in this Section&nbsp;3, this option may not be exercised unless the Participant, at the time he or she
exercises this option, is, and has been at all times since the Grant Date, an employee, officer or
director of, or consultant or advisor to, the Company or any parent or subsidiary of the Company as
defined in Section 424(e) or (f)&nbsp;of the Code (an &#147;Eligible Participant&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Relationship with the Company</U>. If the Participant ceases to be an
Eligible Participant for any reason, then, except as provided in paragraphs (d)&nbsp;and (e)&nbsp;below, the
right to exercise this option shall terminate three months after such cessation (but in no event
</DIV>

<P align="center" style="font-size: 10pt">Page 3 of 7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">after the Final Exercise Date), <U>provided</U> <U>that</U> (i)&nbsp;this option shall be
exercisable only to the extent that the Participant was entitled to exercise this option on the
date of such cessation, and (ii)&nbsp;to the extent that the option or any portion thereof is exercised
at any time later than three months after the date that the Participant ceases to be an employee of
the Company or any parent or subsidiary of the Company as defined in Section 424(e) or (f)&nbsp;of the
Code, the option shall be a non-qualified stock option. Notwithstanding the foregoing, if the
Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality
provisions of any employment contract, confidentiality and nondisclosure agreement or other
agreement between the Participant and the Company, the right to exercise this option shall
terminate immediately upon such violation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise Period Upon Death or Disability</U>. If the Participant dies or becomes
disabled (within the meaning of Section&nbsp;22(e)(3) of the Code) prior to the Final Exercise Date
while he or she is an Eligible Participant and the Company has not terminated such relationship for
&#147;cause&#148; as specified in paragraph (e)&nbsp;below, this option shall be exercisable, within the period of
one year following the date of death or disability of the Participant by the Participant,
<U>provided</U> <U>that</U> (i)&nbsp;this option shall be exercisable only to the extent that this
option was exercisable by the Participant on the date of his or her death or disability, (ii)&nbsp;this
option shall not be exercisable after the Final Exercise Date, and (iii)&nbsp;to the extent that the
option or any portion thereof is exercised at any time later than one year after the Participant&#146;s
termination as an employee of the Company or any parent or subsidiary of the Company (as defined in
Section 424(e) or (f)&nbsp;of the Code) by reason of his or her disability (as defined in Section
22(e)(3) of the Code), the option shall be a non-qualified stock option.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Discharge for Cause</U>. If the Participant, prior to the Final Exercise Date, is
discharged by the Company for &#147;cause&#148; (as defined below), the right to exercise this option shall
terminate immediately upon the effective date of such discharge. &#147;Cause&#148; shall mean willful
misconduct by the Participant or willful failure by the Participant to perform his or her
responsibilities to the Company (including, without limitation, breach by the Participant of any
provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar
agreement between the Participant and the Company), as determined by the Company, which
determination shall be conclusive. The Participant shall be considered to have been discharged for
&#147;cause&#148; if the Company determines, prior to or simultaneously with the Participant&#146;s resignation,
that discharge for cause was warranted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">4. <U>Withholding</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Shares will be issued pursuant to the exercise of this option unless and until the
Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any
federal, state or local withholding taxes required by law to be withheld in respect of this option.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">5. <U>Nontransferability of Option</U>.
</DIV>


<P align="center" style="font-size: 10pt">Page 4 of 7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the
Participant, either voluntarily or by operation of law, except by will or the laws of descent and
distribution, and, during the lifetime of the Participant, this option shall be exercisable only by
the Participant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">6. <U>Disqualifying Disposition</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Participant disposes of Shares acquired upon exercise of this option within two years
from the Grant Date (or, in the case of Shares acquired upon exercise of an Additional Grant, the
date of the Addendum) or one year after such Shares were acquired pursuant to exercise of this
option, the Participant shall notify the Company in writing of such disposition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">7. <U>Provisions of the Plan</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This option is subject to the provisions of the Plan, a copy of which is furnished to the
Participant with this option.
</DIV>

<P align="center" style="font-size: 10pt">Page 5 of 7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal
by its duly authorized officer. This option shall take effect as a sealed instrument.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AKAMAI TECHNOLOGIES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dated: &#171;Grant_Date&#187;
</DIV>




<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>

<TD colspan="3" align="left"><DIV style="font-size: 3pt; margin-bottom: 0pt; width: 100%; border-top: 1px solid #000000">&nbsp;</DIV>
Signature<BR>
Paul Sagan<BR>
President and Chief Executive Officer<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">PARTICIPANT&#146;S ACCEPTANCE
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By accepting this grant, I acknowledge that I have read the Stock Option Plan, related
prospectus, and grant agreement and agree to all terms and conditions set forth therein.
</DIV>

<P align="center" style="font-size: 10pt">Page 6 of 7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;A</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Number of shares as to which this option qualifies as an incentive stock option on the Grant Date:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>&#171;ISO_&#187;</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Number of shares as to which this option is a non-qualified stock option on the Grant Date:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>&#171;NQSO_&#187;</B>
</DIV>



<P align="center" style="font-size: 10pt">Page 7 of 7
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SUBMISSION>
